Published in Vaccine Weekly, November 30th, 2005
This project is funded by a grant awarded to RxKinetix from the foundation for the U.S. National Institutes of Health through the Grand Challenges in Global Health Initiative.
As part of the collaboration, Indian Immunologicals Limited will supply RxKinetix with hepatitis B vaccine, which will be formulated by RxKinetix in its ProJuvant vaccine delivery platform and tested for thermostability. Formulations showing good potential will then be tested in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly